BeOne Medicines Ltd. American Depositary Shares Earnings Dividend

BeOne Medicines Ltd. American Depositary Shares’s revenue jumped 35.46% since last year same period to $1513.44Mn in the Q1 2026. On a quarterly growth basis, BeOne Medicines Ltd. American Depositary Shares has generated 1.02% jump in its revenue since last 3-months.

BeOne Medicines Ltd. American Depositary Shares’s net profit jumped 17802.13% since last year same period to $227.36Mn in the Q1 2026. On a quarterly growth basis, BeOne Medicines Ltd. American Depositary Shares has generated 241.88% jump in its net profits since last 3-months.

BeOne Medicines Ltd. American Depositary Shares’s net profit margin jumped 13116.05% since last year same period to 15.02% in the Q1 2026. On a quarterly growth basis, BeOne Medicines Ltd. American Depositary Shares has generated 238.43% jump in its net profit margins since last 3-months.

BeOne Medicines Ltd. American Depositary Shares’s price-to-earnings ratio after this Q1 2026 earnings stands at 60.98.

BeOne Medicines Ltd. American Depositary Shares’s earning per share (EPS) estimates for the current quarter stand at 1.55 - a 91.36% jump from last quarter’s estimates.

BeOne Medicines Ltd. American Depositary Shares’s earning per share (EPS) estimates for the current year stand at 1.55.

BeOne Medicines Ltd. American Depositary Shares’s earning per share (EPS) jumped 19500% since last year same period to 1.96 in the Q1 2026. This indicates that the BeOne Medicines Ltd. American Depositary Shares has generated 19500% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. BeOne Medicines Ltd. American Depositary Shares’s return on assets (ROA) stands at 0.06.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. BeOne Medicines Ltd. American Depositary Shares’s return on equity (ROE) stands at 0.12.